Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,774 across all filing types
Latest filing 2020-01-30 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' by Morgan Stanley in Evotec SE, referencing German Securities Trading Act (WpHG) sections (Article 40, Section 1, Sec. 33, 34, 38). This type of filing reports changes in significant share ownership thresholds. This directly corresponds to the definition of 'Major Shareholding Notification' (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a detailed disclosure of voting rights attached to shares and instruments, which is the core function of a major holding notification.
2020-01-30 English
EVOTEC AND BAYER ADVANCE FURTHER PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT
Regulatory Filings Classification · 99% confidence The document is a short news release dated January 30, 2020, announcing a corporate development: Evotec's partner Bayer advanced a program into Phase I clinical development and the associated milestone payment. It contains key highlights, quotes from management, and boilerplate company information. It is not a comprehensive financial report (like 10-K or IR), nor is it a transcript (CT) or a formal proxy/remuneration document. Since it is an announcement of a specific corporate event/development (a partnership milestone), it fits best under the general 'Regulatory Filings' (RNS) category, as it is a news item disseminated via DGAP, which often serves as a general regulatory news service for non-standard filings. It is too specific for RNS if a better fit existed, but among the options, it is a general corporate news announcement.
2020-01-30 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'DGAP-DD: Evotec SE english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. This content directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS. The document details the name of the person (Dr. Craig Johnstone), their position, and the specifics of the transaction (price, volume, date).
2020-01-29 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction by Dr. Craig Johnstone, a Member of the managing body, including the date, instrument type (Share), and nature of the transaction (Exercise against cash settlement/Share Performance Plan). This content directly matches the definition for Director's Dealing.
2020-01-29 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' by T. Rowe Price Group, Inc. in Evotec SE, referencing specific German securities laws (WpHG Sections 40, 33, 34, 38). This content directly corresponds to the definition of reporting changes in significant share ownership thresholds. Reviewing the filing definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - DVA (Declaration of Voting Results): This is about holding changes, not the results of a shareholder vote. - MRQ (Major Shareholding Notification): This category perfectly matches the content, which details the acquisition/disposal of shares leading to a change in voting rights percentage (crossing thresholds). Therefore, the classification is MRQ.
2020-01-28 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details the acquisition/disposal of shares with voting rights by Morgan Stanley in Evotec SE, crossing a threshold. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. The filing category 'MRQ' (Major Shareholding Notification) is the most appropriate fit, as it covers notifications of changes in significant share ownership levels crossing thresholds, even though the document header mentions 'Voting Rights Announcements' (which is a type of disclosure often associated with major holdings).
2020-01-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.